Crown (NYSE:CCK – Get Free Report) will likely be announcing its Q1 2026 results after the market closes on Monday, April 27th. Analysts expect the company to announce earnings of $1.75 per share and revenue of $3.0327 billion for the quarter. Crown has set its FY 2026 guidance at 7.900-8.300 EPS and its Q1 2026 guidance at 1.700-1.800 EPS. Investors may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, April 28, 2026 at 9:00 AM ET.
Crown (NYSE:CCK – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The industrial products company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.05. The company had revenue of $3.13 billion during the quarter, compared to analyst estimates of $2.99 billion. Crown had a net margin of 5.97% and a return on equity of 26.68%. Crown’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.59 EPS. On average, analysts expect Crown to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.
Crown Stock Performance
NYSE:CCK opened at $101.22 on Friday. The company has a fifty day moving average of $106.33 and a 200-day moving average of $102.56. The firm has a market capitalization of $11.36 billion, a P/E ratio of 15.89, a P/E/G ratio of 1.69 and a beta of 0.75. The company has a quick ratio of 0.66, a current ratio of 1.03 and a debt-to-equity ratio of 1.55. Crown has a twelve month low of $88.59 and a twelve month high of $116.62.
Crown Increases Dividend
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. UBS Group decreased their price target on shares of Crown from $126.00 to $120.00 and set a “neutral” rating for the company in a research note on Friday, April 10th. JPMorgan Chase & Co. lowered shares of Crown from an “overweight” rating to a “neutral” rating and boosted their price target for the company from $112.00 to $155.00 in a research note on Friday, February 6th. Citigroup decreased their price target on shares of Crown from $128.00 to $127.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Wall Street Zen lowered shares of Crown from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Morgan Stanley restated an “overweight” rating on shares of Crown in a research note on Friday, February 6th. Twelve investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $124.40.
Read Our Latest Research Report on Crown
Insiders Place Their Bets
In other Crown news, COO Djalma Novaes, Jr. sold 29,734 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $114.80, for a total transaction of $3,413,463.20. Following the completion of the sale, the chief operating officer owned 88,052 shares in the company, valued at approximately $10,108,369.60. The trade was a 25.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Timothy J. Donahue sold 7,500 shares of the company’s stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $106.85, for a total transaction of $801,375.00. Following the completion of the sale, the chief executive officer owned 451,070 shares of the company’s stock, valued at approximately $48,196,829.50. The trade was a 1.64% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 59,734 shares of company stock valued at $6,619,863 in the last 90 days. 0.90% of the stock is currently owned by company insiders.
Institutional Trading of Crown
Several institutional investors have recently made changes to their positions in CCK. Sivia Capital Partners LLC purchased a new position in shares of Crown in the 2nd quarter worth about $401,000. Quarry LP boosted its holdings in shares of Crown by 1,107.2% in the 4th quarter. Quarry LP now owns 1,171 shares of the industrial products company’s stock worth $121,000 after buying an additional 1,074 shares during the last quarter. Advisors Asset Management Inc. purchased a new position in shares of Crown in the 4th quarter worth about $122,000. Steward Partners Investment Advisory LLC boosted its holdings in shares of Crown by 74.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,336 shares of the industrial products company’s stock worth $138,000 after buying an additional 568 shares during the last quarter. Finally, Parallel Advisors LLC boosted its holdings in shares of Crown by 12.5% in the 4th quarter. Parallel Advisors LLC now owns 934 shares of the industrial products company’s stock worth $96,000 after buying an additional 104 shares during the last quarter. Institutional investors own 90.93% of the company’s stock.
Crown Company Profile
Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.
Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.
Read More
Receive News & Ratings for Crown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crown and related companies with MarketBeat.com's FREE daily email newsletter.
